QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-fights-stop-manufacturer-tylenol-fraudulently-pa...

 texas-attorney-general-ken-paxton-files-motion-to-prevent-kenvue-from-paying-out-november-dividend

https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-fights-stop-manufacturer-tylenol-fraudulently-pa...

 kenvues-487-billion-sale-puts-consumer-staples-etfs-back-in-vogue

The $48.7 billion Kimberly-Clark–Kenvue deal could reshape major consumer staples ETFs like XLP, VDC, and IYK.

 options-corner-kimberly-clarks-implosion-offers-an-unusual-informational-arbitrage-opportunity

Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative contraria...

 nvidia-amazon-extend-rally-bitcoin-sinks-to-107000-whats-moving-markets-monday

Wall Street opened the week on a mixed note on Monday.

Core News & Articles

Buffett Sells Stocks

Core News & Articles

https://www.wsj.com/business/deals/activist-investors-in-kenvue-faced-big-losses-kimberly-clark-saved-the-day-df6bb04a

 kenvue-affirms-fy2025-adj-eps-guidance-of-100-105-vs-104-est

Kenvue (NYSE:KVUE) affirms FY2025 Adj EPS guidance from $1.00-$1.05 to $1.00-$1.05 vs $1.04 analyst estimate..

 kimberly-clark-stock-plunges-over-16-kenvue-surges-20-in-monday-pre-market-whats-going-on

Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it ann...

 kenvue-q3-adj-eps-028-beats-027-estimate-sales-3764b-miss-3836b-estimate

Kenvue (NYSE:KVUE) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.27 by 5.66 pe...

Core News & Articles

Combines Highly Complementary and Strategically Aligned Consumer Offerings, Including 10 Iconic Billion-Dollar Brands, That Wil...

 hhs-kennedy-on-tylenol-says-not-enough-evidence-to-show-tylenol-definitively-causes-autism-but-some-studies-seem-very-suggestive

https://x.com/US_FDA/status/1983585600214061232

 canaccord-genuity-downgrades-kenvue-to-hold-lowers-price-target-to-15

Canaccord Genuity analyst Susan Anderson downgrades Kenvue (NYSE:KVUE) from Buy to Hold and lowers the price target from $26...

 ken-paxton-alleges-johnson--johnson-misled-mothers-on-tylenol-safety

Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for ...

Core News & Articles

https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-sues-big-pharma-manufacturers-deceptively-marketing-...

 jefferies-maintains-buy-on-kenvue-lowers-price-target-to-23

Jefferies analyst Keith Devas maintains Kenvue (NYSE:KVUE) with a Buy and lowers the price target from $25 to $23.

 president-trump-earlier-sunday-in-truth-social-post-pregnant-women-dont-use-tylenol-unless-absolutely-necessary-dont-give-tylenol-to-your-young-child-for-virtually-any-reason

https://truthsocial.com/@realDonaldTrump/115442316583935494

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION